SOUTH BEND, Ind. (CBS Local) — Researchers at the University of Notre Dame have received $2.9 million to develop a new diagnostic platform that could diagnose cancer in as little as three hours by using only one or two drops of blood.
With the award from the National Institutes of Health, researchers will integrate technologies that will improve the analysis of extracellular RNA (exRNA), which are molecules critical to disease development.READ MORE: COVID In Florida: 5,520 New Cases, 9 Deaths Reported On Sunday
Researchers say exRNA carries information about cellular makeup and, therefore, the release of exRNA from tumor cells may offer important details such as tumor type and size.
With the award from the National Institutes of Health, the team hopes to diagnose cancer in as little as three hours with only a drop or two of blood. https://t.co/zsNqFtuXAb
— WSBT (@WSBT) August 27, 2019READ MORE: Former President Trump Targets McConnell, Pence During Speech To GOP Donors
“Current technology has allowed for the identification of exRNA, but slowly, and the results are typically inefficient and lack the quality needed to determine a diagnosis,” said Hsueh-Chia Chang, the Bayer Professor of Chemical and Biomolecular Engineering and project lead.
“Our proposed diagnostic platform will separate the nanoparticle carriers, release their exRNA cargo and then identify the disease biomarkers, all by integrating an array of technologies invented by our research team here at Notre Dame,” he added.MORE NEWS: ‘Work Gyms’ Helping Remote Employees Be More Productive